Physician profile
Michael Mccarter
NPI 1588654214
$947.53
in general payments reported to CMS, 2019-2025
11 companies · $283 in 2025
The $283 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $69.96 · 2022: $165 · 2023: $61.24 · 2024: $369 · 2025: $283.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $712.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $712.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $216.00 | 2024-2025 | Pico |
| Zimmer Biomet Holdings, INC. | $186.32 | 2021-2024 | Gel-One Cross-Linked Hyaluronate |
| Stryker Corporation | $97.37 | 2024-2025 | Aequalis Perform Reversed |
| Medical Device Business Services, INC. | $97.18 | 2024 | Stratafix |
| Solventum Corporation | $73.56 | 2024 | Prevena Restor Arthroform, Prevena, Ioban 2 |
| Ferring Pharmaceuticals INC. | $68.48 | 2022-2023 | Euflexxa |
| Convatec INC. | $64.50 | 2025 | |
| Heron Therapeutics, INC. | $57.09 | 2024 | Zynrelef |
| Avanos Medical | $47.12 | 2023 | On-Q* Pump and Accessories |
| Vertex Pharmaceuticals Incorporated | $26.04 | 2025 | |
| Bioventus LLC | $13.87 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Mccarter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.